Financials
- Market Capitalization 674.63 M
- Employee 991
- Founded 1998
- CEO Matthew B. Klein
- Website www.ptcbio.com
- Headquarter Delaware, United States
- FIGI BBG000QT15P7
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-29.75
売上高対価格比率
6.9
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2711 | BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 8.52 USD | +2.40% | +0.59% | +9.23% | -10.22% | 682.51 M USD | ||
| 2718 | RLMD Relmada Therapeutics, Inc. - Common Stock | 6.45 USD | +0.62% | +1.74% | -3.30% | +957.38% | 676.54 M USD | ||
| 2728 | ALLO Allogene Therapeutics, Inc. - Common Stock | 1.93 USD | -3.50% | -8.10% | 0.00% | +49.61% | 666.15 M USD | ||
| 2740 | RGNX REGENXBIO Inc. - Common Stock | 12.75 USD | -8.60% | -14.03% | +87.78% | -5.06% | 659.14 M USD |